期刊文献+

Ⅰ_B期及Ⅱ_A期宫颈癌术前介入化疗与术前放疗的疗效观察 被引量:4

Effects of preoperative intraarterial chemotherapy and intracavity brachytherapy radiotherapy in stage ⅠB and ⅡA cervical cancer
下载PDF
导出
摘要 目的:比较ⅠB及ⅡA期宫颈癌术前介入化疗或放疗联合根治手术的疗效,探讨该期宫颈癌患者适宜的治疗方法。方法:选择温州医学院附属第二医院妇产科1998年5月~2003年5月收治的ⅠB和ⅡA期宫颈癌患者138例,所有患者肿瘤均>2cm。按FIGO分期,ⅠB1期24例,ⅠB2期48,ⅡA期66例;按肿瘤大小分为非巨块型(肿瘤直径2~4cm)53例,巨块型(肿瘤直径≥4cm)85例;术前介入化疗74例(化疗组),术前腔内放疗64例(放疗组)。对两组的近期疗效、术后病理组织学变化及中远期疗效进行比较。结果:非巨块型病例化疗组有效率为89.3%,稍高于放疗组88.0%,两组间差异无统计学意义(P>0.05)。巨块型病例化疗组有效率为84.8%,高于放疗组71.8%(P<0.05)。术后病理组织学比较,化疗组淋巴结转移率21.6%,深肌层浸润率21.6%,均低于放疗组的32.8%和34.4%(均P<0.05)。两组宫旁、阴道切缘浸润率及脉管癌栓比较差异无统计学意义(P>0.05)。非巨块型病例化疗组2年复发率为8.8%,5年生存率为83.2%,分别与放疗组10.1%及79.5%比较差异均无统计学意义(P>0.05);巨块型病例化疗组2年复发率为22.5%,5年生存率为81.4%,分别与放疗组31.9%及68.6%比较,均有统计学意义(P<0.05)。结论:巨块型ⅠB和ⅡA期宫颈癌术前应用介入化疗较术前放疗为佳;非巨块型病例术前介入化疗与术前放疗疗效相似。 Objective: To evaluate the better way in the preoperative treatment by comparing preoperative intraarterial chemotherapy and intraeavity braehytherapy radiotherapy in stage I B and ⅡA cervical cancer. Methods: Total 138 patients with stage ⅠB and ⅡA cervical cancer were included and 74 eases were treated with intraarterial chemotherapy (CT) and 64 patients underwent intraeavity braehytherapy radiotherapy (RT) respectively, followed radical hysterectomy to observe recent and forward eurtive effect as well as histopathological ob- servation after operation. Results: ①In CT group the effective rate was 89. 3% in non -bulk cervical cancer (2-4 cm), and eflleeney in bulk tumor (≥4 em) was 84. 8%, slight higher than RT group which were 88. 0% and 71.8% respectively, but no statistical sigaaitleanee was found in non - bulk cervical cancer between two groups. ②In CT group, lymph mode metastaser ( LNM ) and myometrial infiltration were 21.6%, 21.6%, lower than those in RT group 32. 8%, 34. 4% ( P 〈 0. 05 ) ; no other significant numbers were found in surgical specimens between two groups. ③Among bulk turnout patients, in CT group the 2 - year recurrent rate and 5 - year survival rate were 22.5% and 81.4%, wheras those numbers were 31.9% and 68. 6% in RT group, the statistieal significant difference were found between two groups ( P 〈 0. 05 ), but similar results were not found in non - bulk tumors. Conclusion: It is better to take preoperative intraarterial chemotherapy for bulk cervical carcinoma with stage ⅠB and ⅡA.
出处 《中国妇幼保健》 CAS 北大核心 2008年第16期2308-2310,共3页 Maternal and Child Health Care of China
关键词 宫颈癌 术前介入化疗 术前介入放疗 疗效 Cervical cancer Preoperative intraarterial chemotherapy Preoperative intracavity brachytherapy radiotherapy Efficacy
  • 相关文献

参考文献12

  • 1Einhom N, Trope C, Ridderheim M et al. A systematic overview of radiation therapy effects in cervical cancer (cervix uteri) . Aeta Oneol, 2003, 42 (5-6): 546
  • 2Bcskow C, Agren - Cronqvist AK, Granath F et al. Pathologic complete remission after preoperative intracavitary radiotherapy of cervical cancer stage ⅠB and ⅡA is a strong prognostic factor for long - term survival : analysis of the Radiumhcmmct data 1989 - 1991. Int J Gynecol Cancer, 2002, 12 (2): 158
  • 3白萍.宫颈癌术前放射治疗[J].中国实用妇科与产科杂志,2006,22(8):566-568. 被引量:7
  • 4章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 5Mayer A, Nemeskeri C, Poti Z. Evaluation of high - dose - rate braehytherapy of the preoperative treatment of stage ⅠB (FIGO) cervical carcinoma. Magy Onkol, 2004, 48 (2): 141
  • 6Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Werheim - Meigs hyserectomy for a stage ⅠB and ⅡA cervical cancer. Akush Ginekol (Sofila) , 2003, 42 : 22
  • 7Sardi JE, Boixadera MA, Sardi JJ. Neoadjuvant chemotherapy in cervical cancer : a new trend. Curt Opin Obstet Gynecol , 2005, 17 ( 1 ) : 43
  • 8华阳,刘德华,李法庆.选择性子宫动脉栓塞治疗宫颈癌大出血23例[J].中国实用妇科与产科杂志,2003,19(4):255-255. 被引量:10
  • 9Cai HB, Chen HZ, Yin HH.Randomized study of preoperative chemotherapy versus primary surgery for ⅠB cervical cancer. J Obstet Gynaecol Res, 2006, 32 (3): 315
  • 10纪燕琴,黄凤英.新辅助介入化疗对巨块型子宫颈癌的疗效观察[J].肿瘤研究与临床,2006,18(12):824-826. 被引量:9

二级参考文献45

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 2陈亦乐,贺国强,王尔东.髂内动脉灌注新辅助化疗在子宫颈癌治疗中的价值[J].中华妇产科杂志,2005,40(4):231-234. 被引量:46
  • 3周业琴,谭榜宪.116例宫颈癌综合治疗的临床观察[J].中国肿瘤临床,2006,33(2):102-104. 被引量:19
  • 4[1]Vedanrham S,Gooswin SC, Mclucas B,et al. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol, 1997,176 (4) :939
  • 5Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin,1999,49:33-64.
  • 6Minagawa Y, Kigawa J, Irie T, et al. Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervical cancer.Ann Surg Oncol,1998,5:539-543.
  • 7Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage Ⅰ B and Ⅱ A cervical cancer.Akush Ginekol (Sofiia),2003,42:22-24.
  • 8Toita T, Mitsuhashi N, Teshima T, et al.Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34:99-103.
  • 9Frei E 3rd. Clinical cancer research: an embattled species. Cancer,1982, 50:1979-1992.
  • 10Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001, 82:88-93.

共引文献168

同被引文献37

引证文献4

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部